• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Study shows promise of non-drug pain management

, 26 August 2020/in E-News /by 3wmedia

It’s a Catch-22 with potentially deadly consequences: People trying to overcome addiction can’t get treatment for their pain, because the most powerful pain medicines also carry an addiction risk.
And so their pain continues to get in the way of their addiction recovery – or they seek pain relief in the same addictive substances they’re trying to avoid.

But a new study shows the potential for patients to break out of that cycle through a non-drug approach that combines behavioural therapy and social support to help them manage their pain. The low-cost approach, grounded in psychological theories of pain, could help address the nation’s epidemic of addictions to opioid painkillers and illicit drugs.

Veterans who received this pain-focused care while also being treated for addiction found that the intensity of their pain decreased, their ability to function increased, and their alcohol use went down, compared to veterans who received a less-focused approach. However, the two groups had similar rates of drug use.

Just 10 weekly sessions of the approach, called ImPAT for Improving Pain during Addiction Treatment, had an effect that lasted up to a year in 55 veterans who took part, according to the new results published by a team from the VA Ann Arbor Healthcare System’s Center for Clinical Management Research and University of Michigan Medical School’s Addiction Center.

The researchers have already launched a follow-up study in a larger group of 480 non-veterans in a residential addiction treatment program. And the study’s authors note that the ImPAT approach has the potential to be easily and inexpensively adopted by addiction treatment centers and groups worldwide, through team members trained in standard psychological techniques.

Addiction treatment programs often have patients who suffer from chronic pain, but offer few options to treat them, Ilgen says.’These results highlight the need for addiction treatment programs to offer a multifaceted approach that doesn’t only address substance use but also the other factors that might be driving substance use, including pain,’ says Mark Ilgen, Ph.D., the study’s lead author and a VA and U-M psychologist specializing in addiction research. ‘We’ve shown that it’s possible to improve pain outcomes in people with addiction, and even have some spillover effects on their substance use.’

To make matters worse, ‘Past studies of psychosocial approaches for pain have often excluded people with drug or alcohol problems, addiction treatment programs do not usually have providers trained in pain care, and many pain specialists will not treat people who also have addiction. So patients are caught in the middle.’

All 129 patients in the study, most of them men in their 40s and 50s, were receiving outpatient addiction treatment in a CBT-based, non-abstinence setting at the Ann Arbor VA. Half were randomly assigned to ImPAT sessions, the other half to support groups of peers, led by a therapist, where pain and addiction could be discussed.

ImPAT combines elements of cognitive behavioural therapy with another psychosocial approach called acceptance and commitment therapy.

While the two approaches aren’t usually used together, they are often used in pain treatment settings – but those clinics and programs don’t often accept people who also acknowledge they have addiction issues. Ilgen and his colleagues hope their results will help bring the techniques into addiction treatment settings, where the cognitive behavioural therapy approach is often used.

The ImPAT technique seeks to use integrated approaches both to help patients focus less on their pain and more on other aspects of life. This includes techniques to help people adapt to their pain, find ways to distract themselves from their pain, and think of ways to function in the face of pain.

‘We want to take the focus off pain and put it onto functioning, and finding pleasurable ways to spend time,’ Ilgen says. ‘There’s also a strong link between depression and pain. Pain is responsive to mood, and mood is responsive to social support.’

University of Michigan www.uofmhealth.org/news/archive/201607/treating-pain-without-feeding-addiction-study-shows-promise

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:19Study shows promise of non-drug pain management

Study assesses performance of direct-to-consumer teledermatology services

, 26 August 2020/in E-News /by 3wmedia

A study that used fake patients to assess the performance of direct-to-consumer teledermatology websites suggests that incorrect diagnoses were made, treatment recommendations sometimes contradicted guidelines, and prescriptions frequently lacked disclosure about possible adverse effects and pregnancy risks, according to an article.
In the US, direct-to-consumer teledermatology (DTC) is rapidly expanding and large DTC services are contracting with major health plans to provide telecare. However, relatively little is known about the quality of these services.
Jack S. Resneck, Jr., M.D., of the University of California, San Francisco, and co-authors used study personnel posing as patients to submit six dermatologic cases with photographs, including neoplastic, inflammatory and infectious conditions, to regional and national DTC telemedicine websites and smartphone apps offering services to California residents. The photographs were mostly obtained from publicly available online image search engines. Study patients claimed to be uninsured and paid fees using Visa gift debit cards; no study personnel provided any false government-issued identification cards or numbers.
The authors received responses from 16 DTC websites for 62 clinical encounters over about a month from February to March 2016.
The authors report:
None of the websites asked for identification or raised concern about pseudonym use or falsified photographs.
During 68 percent of encounters, patients were assigned a clinician without any choice; 26 percent disclosed information about clinician licensure; and some used internationally based physicians without California licenses; 23 percent collected the name of an existing primary care physician and 10 percent offered to send records.
A diagnosis or a likely diagnosis was given in 77 percent of cases; prescriptions were ordered in 65 percent of these cases; and relevant adverse effects or pregnancy risks were disclosed in a minority of those.
The websites made several correct diagnoses in cases where photographs alone were adequate but when additional history was needed they often failed to ask simple, relevant questions.
Major diagnoses were missed including secondary syphilis, eczema herpeticum, gram-negative folliculitis and polycystic ovarian syndrome.
Treatments prescribed were sometimes at odds with guidelines.
A significant limitation to this study is that the authors were unable to assess whether clinicians seeing these patients in traditional in-person encounters would have performed any better.
The authors offer a series of recommended practices for DTC telemedicine websites, including obtaining proof of patient identity, collecting relevant medical history, seeking laboratory tests when an in-person physician would have relied on that information, having relationships with local physicians in all the areas where they treat patients, and creating quality assurance programmes.

JAMAhttp://tinyurl.com/hctx7t5

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:27Study assesses performance of direct-to-consumer teledermatology services

Researchers develop brain-mapping technology

, 26 August 2020/in E-News /by 3wmedia

Researchers at the University of Arizona are developing a non-invasive brain-scanning technology that could produce images far superior to those obtained with the most commonly used systems – electroencephalography and functional magnetic resonance imaging.
The technique, which incorporates sound waves to measure electrical activity in neural tissue, could improve diagnosis and treatment of many disorders, including epilepsy, Parkinson’s disease and traumatic brain injury.
Russell Witte, a UA associate professor of medical imaging, biomedical engineering and optical sciences, is principal investigator of the research project.
‘We know very little about how neurons act collectively to guide our thoughts, emotions and behaviours – or cause seizures or mood swings,’ Witte said.
‘Functional magnetic resonance imaging and electroencephalography have provided some clues. But both fMRI and EEG share a major limitation: They produce images with poor resolution,’ he said. ‘We think our new technology could overcome that limitation.’
Researchers have long known of the acoustoelectric effect, in which ultrasound energy alters a material’s physical properties like electrical conductivity.
Witte is one of the first researchers to apply the phenomenon to biomedical imaging.
He has developed a non-invasive imaging technique for detecting irregular heartbeats and is working with Tech Launch Arizona, the UA office that commercializes inventions stemming from University research, to create a startup for acoustoelectric cardiac imaging.
With the new study, Witte takes his research into new terrain: the brain.
The research team will develop and test the non-invasive technology, called acoustoelectric brain imaging, or ABI, on mammalian brains for the first time.
ABI involves applying ultrasound waves externally to the brain, where they interact with electrical currents to produce a ‘signature’ wave that is picked up by an electrode attached outside the head. ABI can better localize the source of electrical activity than EEG, because it overcomes the problem of interference from the skull, and it works much faster than fMRI, which measures metabolic activity.
‘Sensory input, thoughts and behaviours are happening so fast,’ said Cowen, a neuroscientist.
‘With speech or motor activity, many actions require split-second decisions – actually, on the scale of tens of milliseconds,’ Cowen said. ‘If a brain-imaging technology is working only in seconds – fMRI, for example, can measure brain activity once every two seconds – it may be missing some of the most important details.’
Cowen added: ‘This is a very interesting adventure we’re undertaking, because nobody knows what ABI will actually measure. Will it measure the activity of tens of thousands, or hundreds of thousands, of neurons? Will it detect the activity at a specific frequency, or at a range of frequencies?’
ABI also could provide a clearer picture of activity in structures deep in the brain, such as the amygdala and hippocampus.

University of Arizona http://tinyurl.com/zw5f6he

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:06Researchers develop brain-mapping technology

Researchers use gene therapy to extend estrogen’s protective effects on memory

, 26 August 2020/in E-News /by 3wmedia

The hormone oestrogen helps protect memory and promote a healthy brain, but this effect wanes as women age, and even estrogen replacement therapy stops working in humans after age 65. Now researchers at University of Florida Health have used gene therapy in a rat model to show that the expression of a particular receptor can reinstate lost memory function.
The scientists included Thomas C. Foster, Ph.D., a professor of neuroscience and the Evelyn F. McKnight chair for research on cognitive aging, and Linda A. Bean, Ph.D.
‘There is a window of time, starting around menopause, when initiation of hormone replacement therapy with estrogen protects the brain against injury and Alzheimer’s disease. However, this window seems to end around age 65,’ Foster said. ‘We wanted to find out what is regulating this window.’
The researchers used gene therapy to overexpress two different estrogen receptors found in the hippocampus, a part of the brain essential to memory regulation. They found that an abundance of one of these receptors, called alpha, reinstated memory in aging rats when paired with estrogen.
Estrogen helps to do this by increasing the brain’s ‘plasticity,’ which is the ability to form and maintain connections between brain cells as things are learned. As plasticity declines, so do the number of connections in the brain, and certain types of memories begin to fade. Without the protective effect of estrogen, women may lose brain plasticity and start forgetting things more often. The loss of estrogen’s protective effects may explain why women are more likely than men to develop dysfunctional memory problems such as Alzheimer’s disease.
The researchers looked at the effects on memory in six groups, which received gene therapy for expression of the alpha receptor, the beta receptor or a control gene. The three different gene therapy groups then received estrogen or a placebo for the next several weeks, until memory testing and examination of brain plasticity. The project involved 72 animals. Only the group with gene therapy for the alpha receptor plus estrogen showed any beneficial effects on memory and increased brain plasticity markers.
‘In the short term, this finding helps us understand how estrogen rescues memory and keeps the brain young and plastic,’ Foster said. ‘In the long term, this finding may eventually allow us to bypass estrogen and target the receptor or brain plasticity mechanisms directly.’

University of Florida Health http://tinyurl.com/qbkrmz9

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:14Researchers use gene therapy to extend estrogen’s protective effects on memory

Optical magnetic field sensor can detect signals from the nervous system

, 26 August 2020/in E-News /by 3wmedia

The human body is controlled by electrical impulses in, for example, the brain, the heart and nervous system. These electrical signals create tiny magnetic fields, which doctors could use to diagnose various diseases, for example diseases of the brain or heart problems in young foetuses. Researchers from the Niels Bohr Institute have now succeeded in developing a method for extremely precise measurements of such ultra-small magnetic fields with an optical magnetic field sensor.

Small magnetic fields from the human body can usually only be picked up by very sensitive superconducting magnetic field sensors that have to be cooled by liquid helium to near absolute zero (which is minus 273 degrees Celsius). But now researchers from the Niels Bohr Institute at the University of Copenhagen have developed a much cheaper and more practical optical magnetic field sensor that even works at room temperature or at body temperature.

‘The optical magnetic field sensor is based on a gas of caesium atoms in a small glass container. Each caesium atom is equivalent to a small bar magnet, which is affected by external magnetic fields. The atoms and thus the magnetic field are picked up using laser light. The method is based on quantum optics and atomic physics and can be used to measure extremely small magnetic fields,’ explains Kasper Jensen, assistant professor in the Center for Quantum Optics, Quantop at the Niels Bohr Institute at the University of Copenhagen.

The researchers at the Niels Bohr Institute have been developing the sensitive magnetic field sensor for several years in the Quantum research group laboratories.

The magnetic field sensor itself consists of a glass container, which has a channel that is approximately 1cm long and 1 mm wide. At the bottom of the glass container is caesium metal. Caesium evaporates into gas at room temperature and the gas atoms rise up into the small channel in the sensor head. Each caesium atom rotates around itself and the axis is like a tiny bar magnet. Now the sensor is held close to a nerve, which emits an electrical nerve pulse. The electrical pulse has a magnetic field that causes a change in the tilt of the axes of the caesium atoms and by sending a laser beam through the gas, you can read the ultra-small magnetic fields of the nerve signals.

The laboratory tests, which were carried out in collaboration with researchers from the Faculty of Health and Medical Sciences, have shown that you can use the magnetic field sensor to detect the magnetic fields from the electrical impulses from the nervous system. The tests were done on the sciatic nerve from a frog, which in many ways resemble the nerves in the human body. For practical reasons, the nerve was removed from the frog before the tests, but it is also possible to pick up electrical impulses from live frogs or from humans.

The advantage of the optical sensor is precisely that the magnetic fields and electrical impulses can be safely and easily picked up at a distance of a few millimetres or centimetres – without the sensor actually coming into contact with the body.

‘We expect that the sensor will be used for special medical examinations, where it is important for the sensor not to be directly in contact with the body, for example, for diagnosing heart problems in tiny foetuses. Here the magnetic field sensor is placed on the mother’s abdomen and you can easily and safely detect the heartbeat of the foetus and you will be able to diagnose any heart problems at an early stage so that the foetus can get the right treatment quickly,’ explains Eugene Polzik, professor and head of Quantop at the Niels Bohr Institute.

University of Copenhagen Niels Bohr Institute news.ku.dk/all_news/2016/07/optical-magnetic-field-sensor-can-detect-signals-from-the-nervous-system/

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:22Optical magnetic field sensor can detect signals from the nervous system

Helmet-based ventilation is superior to face mask for patients with respiratory distress

, 26 August 2020/in E-News /by 3wmedia

A new study shows that using a transparent air-tight helmet instead of a face mask helps critically ill patients breathe better and can prevent them from needing a ventilator. Patients with helmet ventilation also spent less time in the intensive care unit and had better survival.
The study followed 83 patients suffering from acute respiratory distress syndrome (ARDS), a severe, often lethal, injury to the lungs. ARDS causes fluid to accumulate in the lungs’ microscopic air sacs. It can lead to partial collapse of the lungs, dangerously low blood-oxygen levels and death.
The subjects in this study all required mechanical breathing assistance. They were randomly assigned to receive some form of non-invasive ventilation, using either a standard mask, strapped onto the face and covering the nose, mouth and chin; or the helmet, which surrounds the patient’s entire head and is sealed with a soft air-tight collar that wraps around the patient’s neck.
A primary goal of non-invasive ventilation is to prevent intubation, placement of a tube through the mouth or nose into the trachea to pump air into the lungs. Complications of endotracheal intubation are common. They include pneumonia, the need for strong sedatives, and delirium.
‘In this group of critically ill patients, the helmet made a substantial difference,’ said pulmonologist John P. Kress, MD, professor of medicine at the University of Chicago and senior author of the study. ‘The University’s data and safety monitoring board recommended that we stop the trial early because the helmet consistently demonstrated multiple advantages, particularly the reduced need to intubate patients and longer-term reduction in mortality.’
‘After reviewing our data,’ he added, ‘the board felt that it would be difficult to justify enrolling more patients in the face-mask arm of the trial, which exposed them to greater risks.’
The helmet ‘confers several advantages over the face mask,’ the authors wrote. It is less likely to leak. This enables the care team to increase air pressure into the helmet, which helps keep the airway and lungs open and improves oxygen levels. It is also more comfortable, easier to tolerate because it doesn’t touch the face, and patients can see through it well enough to watch television, talk or read.
Patients who required the face mask for oxygenation for at least 8 hours were eligible to enroll in the study. Forty-four of the 83 patients who qualified to participate were then randomly assigned to the helmet group. The other 39 were assigned to the face-mask group.
All patients were severely ill with a 50 percent risk of requiring intubation or dying in the intensive care unit. About half of the patients had weakened immune systems from cancer or transplantation.
Patients in the helmet group, however, were three times less likely to require intubation, the study’s primary endpoint. Only 18.2 percent of those wearing a helmet required an endotracheal tube, versus 61.5 percent of those wearing a face mask. The helmet group had, on average, more ventilator-free days (28 vs 12.5).
Helmet patients were also more likely to survive. When compared at 90 days, 34 percent (15 patients) in the helmet group had died, compared to 56 percent (22 patients) in the face mask group.
Adverse trial-related events were minor. They included 3 skin ulcers for each group.
‘The helmet interface has unique advantages and disadvantages,’ wrote Jeremy Beitler, MD, MPH, of the University of California, San Diego, in an accompanying editorial. ‘Careful selection of patients is important.’ This approach, he wrote, ‘warrants testing in a multi-centre trial.’
‘These findings build on a shifting paradigm where less is more in the care of critically ill patients,’ said Bhakti Patel, MD, clinical instructor of medicine at the University and first author of the study. ‘We have chosen less sedation for more mental animation; less bed rest for more physical activity; and now we’re choosing less intubations for more non-invasive ventilation.’

University of Chicago http://tinyurl.com/hqt2bnv

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:09Helmet-based ventilation is superior to face mask for patients with respiratory distress

Importance of testing and prevention in response to confirmed local transmission of Zika Virus

, 26 August 2020/in E-News /by 3wmedia

Florida health officials and the Centers for Disease Control and Prevention (CDC) today confirmed local transmission of the Zika virus in a specific area of Dade and Broward Counties in Florida, emphasizing the need for robust, ongoing Zika surveillance and response preparedness wherever Zika-transmitting mosquitos are found in the US. Infectious diseases physicians are urging the public to take measures to protect themselves from contracting the virus while also urging Congress to provide the funding necessary for an appropriate public health response.

Zika is most commonly spread by infected Aedes species mosquitoes, therefore, preventing mosquito bites in areas where Zika is present is essential, especially for pregnant women. The most effective way to prevent mosquito bites is by using an EPA-registered insect repellent, wearing long sleeves and pants, removing standing water from around your home, and staying indoors. It is important to know that Zika can also be transmitted sexually by a man or a woman, so all who may have been exposed to Zika and are partners of a pregnant woman are urged to use a condom or abstain from sex for the duration of pregnancy to prevent the spread of the virus. Zika is known to cause a serious birth defect called microcephaly, and other problems in pregnancies and among foetuses and infants infected with the virus before birth. Guillain-Barre syndrome (GBS), an uncommon sickness of the nervous system, is also very likely triggered by Zika in a small number of cases.

Most people infected with Zika will have mild or no symptoms at all. A blood or urine test can confirm whether a patient is infected, and patients are urged to consult their healthcare provider if they are concerned that they have been exposed to the virus.

Pregnant women should talk to a doctor or other healthcare provider if they or their sex partners recently travelled to an area with Zika, even if they don’t feel sick. Others who have travelled to areas with Zika should see their doctors if they experience any Zika symptoms, such as fever, joint pain, rash, red eyes, muscle pain or headache. Physicians may collect blood or urine samples for Zika virus testing.

IDSA www.idsociety.org/Press_Release_07_29_2016/

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:17Importance of testing and prevention in response to confirmed local transmission of Zika Virus

Samsung’s diagnostic ultrasound Crystal Vue’ featured on cover of leading academic journal

, 26 August 2020/in E-News /by 3wmedia

Samsung Medison, an affiliate of Samsung Electronics, announced that its latest imaging technology Crystal Vue’ has been featured on the front cover of Ultrasound in Obstetrics & Gynecology (UOG), a renowned academic journal in the women’s healthcare industry and the official journal published by the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG).
The March edition of the UOG featured a clinical case study by Dr. Christoph Lees, professor at the Department of Surgery & Cancer within the Faculty of Medicine at Imperial College in London. Using Samsung’s premium diagnostic ultrasound system WS80A, Professor Lees introduced two cases of prenatal imaging through Crystal Vue, of which the rib & vertebral images were selected as the Picture of the Month by UOG.
‘Our experience with Crystal Vue over the past few months, specifically imaging of the bone and soft tissue interface, leads us to believe that it may offer new opportunities for prenatal imaging, particularly for the skeletal system, but also in facial and brain imaging,’ Professor Lees stated in his study. ‘We were able to obtain highly detailed images that give particular information on the contour of the ribs and allow inference on mineralization.’
Crystal Vue is an advanced 3D volume rendering technology that enables users to assess detailed information of internal and external structures of the fetus or uterus and helps easily differentiate between the soft tissue and bone. With the additional morphological information, users may deepen their understanding of the patients and fetus.
Crystal Vue was first introduced at the 25th World Congress on Ultrasound in Obstetrics and Gynecology, held in Canada in October 2015, as the latest imaging function of the WS80A. The WS80A with Crystal Vue is currently available globally.
‘We are thrilled that Samsung’s latest technology was recognized in a leading academic journal as a new diagnostic imaging that can provide more clinical values in women’s health,’ said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. ‘With Samsung’s leading display and software technology, we will continue to develop new features that can increase diagnosis confidence and contribute to women and fetal health.’

www.samsung.com
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:25Samsung’s diagnostic ultrasound Crystal Vue’ featured on cover of leading academic journal

Cycling in bed is safe for ICU patients

, 26 August 2020/in E-News /by 3wmedia

Early bicycle exercise during their stay in a hospital intensive care unit (ICU) may help some patients recover more quickly.
Researchers at McMaster University and St. Joseph’s Healthcare Hamilton have demonstrated that physiotherapists can safely start in-bed cycling sessions with critically ill, mechanically ventilated patients early on in their ICU stay.
‘People may think that ICU patients are too sick for physical activity, but we know that if patients start in-bed cycling two weeks into their ICU stay, they will walk farther at hospital discharge,’ says the study’s lead author Michelle Kho, an assistant professor with the School of Rehabilitation Science at McMaster University and physiotherapist at St. Joseph’s Healthcare Hamilton.
‘Our TryCYCLE study builds on this previous work and finds it is safe and feasible to systematically start in-bed cycling within the first four days of mechanical ventilation and continue throughout a patient’s ICU stay.’
Patients who survive their ICU stay are at high risk for muscle weakness and disability, and muscle atrophy and weakness starts within days of a patient’s admission to the ICU. Cycling targets the legs, especially the hip flexors, which are most vulnerable to these effects during bed rest.
By strengthening their muscles and overall health, patients may go home sooner, stronger and happier. This not only benefits the patient, but could alleviate the high cost of critical care for the healthcare system. TryCYCLE is the first of a series of studies that will determine the effects of early in-bed cycling with critically ill patients.
Over a year, Kho and her team conducted a study of 33 patients in the ICU at St. Joseph’s Healthcare Hamilton. The special in-bed cycling equipment was provided by the St. Joseph’s Healthcare Foundation.
Patients were 18 years of age or older, receiving mechanical ventilation, and walking independently prior to admission to the ICU. The treatment in the ICU was 30 minutes of supine cycling using a motorized stationary bicycle affixed to the bed, six days a week.
The researchers found that early cycling within the first four days of mechanical ventilation among patients with stable blood flow is safe and feasible. Patients started cycling within the first three days of ICU admission and cycled about 9 km on average during their ICU stay.

McMaster University http://tinyurl.com/h7bqgbv

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:37:362020-08-26 14:37:38Cycling in bed is safe for ICU patients

Remarkable recovery in patients diagnosed with newly defined movement disorder

, 26 August 2020/in E-News /by 3wmedia

Researchers from the UCL GOS Institute of Child Health have discovered a new gene change that identifies a type of the movement disorder, muscle dystonia. This new discovery will allow doctors to more easily identify patients who can benefit from treatment so effective that it can restore the ability to walk.
The team from UCL Great Ormond Street Institute of Child Health, along with colleagues at the University of Cambridge and the NIHR Rare Disease Bioresource, identified a change in a gene, called KMT2B, in 28 patients who had dystonia.

Dystonia is one of the most common movement disorders and is thought to affect 70,000 people in the UK. It can cause a wide range of disabling symptoms, including painful muscle spasms and abnormal postures, and can affect walking and speech. In most of the 28 cases, the patients – many of whom were young children who were thought to have a diagnosis of cerebral palsy – were unable to walk.

For some patients, treatment with Deep Brain Stimulation, in which electrical impulses are delivered to a specific area in the brain, either restored or significantly improved independent walking and improved hand and arm movement. In one patient, improvements have been sustained over six years.

Given the findings, the team now suggest that testing for these changes in the gene should form part of standard testing for patients with dystonia. This will allow the most effective treatment to be offered to patients early on.

Dr Manju Kurian, paediatric neurologist at Great Ormond Street Hospital and lead researcher on the paper, says ‘Through DNA sequencing, we have identified a new genetic movement disorder that can be treated with Deep Brain Stimulation. This can dramatically improve the lives of children with the condition and enable them to have a wider range of movement with long-lasting effects,’

‘Remarkably nearly all patients who had Deep Brain Stimulation showed considerable improvements. One patient was able to walk independently within two weeks; in five patients, the improvement has lasted for more than three years. It is an astounding result.’

Former GOSH patient, Dominika, aged 21, was diagnosed with dystonia when she was 13 and had deep brain stimulation treatment two years ago:

When I was young I was able to speak and write normally but I started to have problems with walking when I was about 10. By the time I was 11 or 12, my walking had got worse and I started to notice my writing and speech was deteriorating.
Throughout high school, I had lots of different tests to try and find out what was wrong with me and I first came to GOSH just after my 13th birthday. They gave me lots more tests and told me that I had a type of dystonia which means my muscles aren’t working properly and I can’t move my body as well as I should.

By the time I got to the last year in high school, I was finding walking very difficult and so I started using a wheelchair because it was easier and less painful.

I was given a drug treatment for my dystonia but it didn’t seem to be making things much better so when I was 19, I was offered deep brain stimulation surgery.

Since the operation, life has been good and the surgery has really changed things for me. It has allowed me to walk around mostly unaided. I have seen a big difference with my hands – I can now write and draw, something I wasn’t able to do before. Now, I just do physiotherapy exercises at home to keep my movement as strong as possible. This has meant that I have been able to go to university and I am currently in my final year studying Computer Game Art. I get to practise my drawing using traditional and digital media, and hopefully one day I can get a job doing the two things I love best, drawing and playing video games.

Great Ormond Street Hospital for Children www.gosh.nhs.uk/news/latest-press-releases/2016-press-releases/remarkable-recovery-patients-diagnosed-newly-defined-movement-disorder-0

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:37:362020-08-26 14:37:46Remarkable recovery in patients diagnosed with newly defined movement disorder
Page 177 of 236«‹175176177178179›»

Latest issue of International Hospital

April 2024

13 October 2025

Global mortality rates fall sharply, but youth deaths surge in stark health divide

9 October 2025

electronRx launches pDx app for remote lung monitoring

9 October 2025

Hospital teams reduce unnecessary preoperative testing by tailoring strategies to local workflows

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription